Established 1999
     
8,000 companies from USA and India.  
   
Search over 34,500 News & Earnings Database    
 
Earnings Calls: 
Merck & Co Earnings Call, Second Quarter 2008
Author: Maclintosh Kuhlengisa
123jump.com
Last Update: 11:02 AM ET July 24 2008
123Jump:


(Continued)

Email article | Print article

The pharmaceutical company reported earnings of $1.77 billion or 86 cents a share, up 5% over $1.68 billion or 77 cents a share in 2007, reflecting continued efforts to create a leaner, more cost effective and customer-focused operating model. Revenue was down 1%, to $6.05 billion from $6.1 billion in the prior year due to challenges to key brands, such as GARDASIL and SINGULAIR, and the continued impact of the loss of marketing exclusivity for FOSAMAX.

Investors Question and Answers

 
 Company Website Links:
Investor Relations Financial Info Corporate / History Profile Executives Products Services
 
You need to upgrade your Flash Player


You need to upgrade your Flash Player

 
We think those are the kinds of things that we will have to do in order for us to drive greater awareness during the course of the year. We have distributed a significant number of doses. The penetration has been 30 million worldwide and 18 million in the U.S.

David Risinger (Merrill Lynch): Could you just run through the filed vaccine supplements?

Richard T. Clark: We have at least two supplements with the FDA concerning GARDASIL and they will move through the process now.

Catherine Arnold (Credit Suisse): Comment on the ZOSTAVAX performance?

Kenneth C. Frazier: Due to the supply issues that had existed with varicella containing vaccine, we prioritize VARIVAX, particularly to ensure that we had a supply to support the second dose vaccination recommendations. As a result, we were not in the same way publicizing or promoting ZOSTAVAX.
  1  2  3 More: Earnings Calls

 
 
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2010 123jump.com. All rights reserved